Summary:
With national pharmacare closer to reality in Canada, our insightful conversation with market access professionals and seasoned pharmacists, Sang Mi Lee, MBA, BSc Phm, RPh and Brian O’Rourke, sheds light on the intricacies of Canada’s drug reimbursement system and how it might evolve with the recent creation of the Canadian Drug Agency (CDA).
Sang Mi is an Executive Director at MORSE Consulting Inc., and former senior manager & senior pharmacist at pan-Canadian Pharmaceutical Alliance. Brian is President of ISPOR—The Professional Society for Health Economics and Outcomes Research, and former President and CEO of CADTH.
Dive into the discussion as we tackle questions about this new agency and importance of real world evidence, including the CDA’s anticipated role and the impact on Canadians.
Podcast:
